A New Assay for Measurement of the Liberated Domain I of the Urokinase Receptor in Plasma Improves the Prediction of Survival in Colorectal Cancer - Concepedia

Concepedia

Publication | Open Access

A New Assay for Measurement of the Liberated Domain I of the Urokinase Receptor in Plasma Improves the Prediction of Survival in Colorectal Cancer

DOI Full Paper Access

37

Citations

16

References

2010

Year

Tine Thurison, Anne Fog Lomholt, Morten G. Rasch, Ida Katrine Lund, Hans Jørgen Nielsen, Ib Jarle Christensen, Gunilla Høyer‐Hansen

Clinical Chemistry

Abstract

TR-FIA 4 has a functional sensitivity improved 4-fold over that of the previous uPAR(I) assay. The uPAR(I) concentration measured with TR-FIA 4 is an independent predictor of prognosis in CRC patients.

References

	Year	Citations

Page 1